Zhejiang
605177.SSZhejiang East Asia Pharmaceutical Co., Ltd. Price (605177.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
124,999,380
(10.0347)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 684,465,400 | 728,890,639 | 856,812,186 | 988,087,656 | 881,670,693 | 712,218,140 | 1,179,556,669 | 1,356,448,097 |
| Net Income | 66,747,500 | 55,742,650 | 109,337,364 | 168,328,907 | 114,481,599 | 68,492,057 | 104,425,976 | 121,249,399 |
| FCF USD | 14,235,300 | 63,479,033 | 114,174,176 | 158,844,976 | 85,821,623 | -145,573,727 | -158,170,185 | -311,534,911 |
| OCF USD | 54,350,200 | 91,659,236 | 143,644,625 | 216,629,368 | 146,903,140 | -23,599,392 | -70,350,584 | -84,061,908 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.12 | 0.00 | 0.06 | 0.00 | 0.03 | 0.23 | 4.81 |
| D/E | 0.77 | 0.44 | 0.14 | 0.02 | 0.01 | 0.00 | 0.07 | 0.35 |
| CA/CL | 0.82 | 1.18 | 1.50 | 2.35 | 4.41 | 2.61 | 2.09 | 2.50 |
| TA/TL | 1.71 | 2.18 | 2.86 | 4.28 | 5.92 | 4.57 | 3.91 | 2.52 |
| Total Debt | 330,000,000 | 279,000,000 | 98,500,000 | 20,000,000 | 10,013,291 | 2,383,646 | 122,758,446 | 703,110,855 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 8.17% | 5.86% | 13.53% | 19.17% | 6.62% | 3.89% | 5.48% | 4.45% |
| ROE | 15.66% | 8.82% | 15.38% | 19.85% | 6.62% | 3.90% | 5.68% | 6.02% |
| ROA | 0.00% | 4.78% | 10.00% | 15.21% | 5.50% | 3.04% | 4.23% | 3.63% |
| NM % | 9.75% | 7.65% | 12.76% | 17.04% | 12.98% | 9.62% | 8.85% | 8.94% |
| FCF / R% | 0.00% | 8.71% | 13.33% | 16.08% | 9.73% | -20.44% | -13.41% | -22.97% |
| FCF / NI% | 21.33% | 113.88% | 104.42% | 94.37% | 74.97% | -212.54% | -151.47% | -256.94% |
| Operating Margin (OM) | 0.00 | 0.23 | 0.29 | 0.38 | 0.53 | 0.68 | 0.47 | 0.47 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.89 | 0.71 | 1.28 | 1.48 | 1.01 | 0.60 | 0.92 | 1.08 |
| SPS | 9.13 | 9.28 | 10.03 | 8.70 | 7.76 | 6.27 | 10.38 | 12.05 |
| OCPS | 0.72 | 1.17 | 1.68 | 1.91 | 1.29 | -0.21 | -0.62 | -0.75 |
| FCPS | 0.19 | 0.81 | 1.34 | 1.40 | 0.76 | -1.28 | -1.39 | -2.77 |
| BVPS | 5.68 | 8.05 | 8.32 | 7.47 | 15.23 | 15.48 | 16.20 | 17.90 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.89 | 0.71 | 1.28 | 1.48 | 1.01 | 0.60 | 0.92 | 1.08 |
| CAGR-SPS | 9.13 | 9.28 | 10.03 | 8.70 | 7.76 | 6.27 | 10.38 | 12.05 |
| CAGR-OCPS | 0.72 | 1.17 | 1.68 | 1.91 | 1.29 | -0.21 | -0.62 | -0.75 |
| CAGR-FCPS | 0.19 | 0.81 | 1.34 | 1.40 | 0.76 | -1.28 | -1.39 | -2.77 |
| CAGR-BVPS | 5.68 | 8.05 | 8.32 | 7.47 | 15.23 | 15.48 | 16.20 | 17.90 |